Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.35 |
| ▸ | CA2 | P00918 | 8/20 | 0.35 |
| ▸ | CA4 | P22748 | 7/20 | 0.35 |
| ▸ | CA12 | O43570 | 6/20 | 0.35 |
| ▸ | CA9 | Q16790 | 6/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.34 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8428341 | 1.00 | CA1 (0.35) | CA1CA2CA4CA12CA9 | |
| SCHEMBL8428757 | 0.88 | MIF (0.44) | CA1CA2CA4CA12CA9 | |
| SCHEMBL8431937 | 0.88 | MIF (0.44) | CA1CA2CA4CA12CA9 | |
| SCHEMBL8431678 | 0.88 | MIF (0.44) | CA1CA2CA4CA12CA9 | |
| SCHEMBL10739997 | 0.82 | CA1 (0.39) | CA1CA2CA4CA12CA9 | |
| SCHEMBL8521003 | 0.81 | PTGS2 (0.45) | CA1CA2CA4CA12CA9 | |
| SCHEMBL10611496 | 0.80 | CA2 (0.40) | CA1CA2CA4CA12CA9 | |
| SCHEMBL8432320 | 0.77 | CA2 (0.41) | CA1CA2CA4CA12CA9 | |
| SCHEMBL8430256 | 0.77 | CA2 (0.40) | CA1CA2CA4CA12CA9 | |
| SCHEMBL8430301 | 0.77 | CA2 (0.40) | CA1CA2CA4CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5965619-A | ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION | CELL PATHWAYS INC. (US) | 1999-10-12 | — | — | US | disclosed |